GMAB : Should Expect Sideways To Lower Before Upside Resumes
Genmab A/S (GMAB) develops antibody therapeutics for the treatment of the cancer and other diseases. The company is based in Copenhagen, Denmark, comes under Healthcare – Biotechnology sector & trades as “GMAB” ticker at Nasdaq. GMAB made...